Загрузка...
FLT3 inhibitor design using molecular docking based virtual screening for acute myeloid leukemia
Acute Myeloid Leukaemia (AML) is a blood cancer, which affects the red blood cells in the bone marrow. Of the possible proteins that are affected in AML, fms-like tyrosine kinase 3 (FLT3) has long been recognized as a potential therapeutic target as it affects the other signaling pathways and leads...
Сохранить в:
| Опубликовано в: : | Bioinformation |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Biomedical Informatics
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6677903/ https://ncbi.nlm.nih.gov/pubmed/31435156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6026/97320630015104 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|